In the last decades, TFEB, the main regulator of autophagy, has been found to be dysregulated in HD [35, 56], and approaches aimed to activate the TFEB pathway, with exogenous TFEB expression or with pharmacological activation, facilitate muHTT clearance and ameliorate disease phenotype [53, 57, 58]. Here, TFEB is linked to Huntington disease.